Ameriprise’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,326
Closed -$54.7K 4035
2024
Q4
$54.7K Sell
17,326
-645,170
-97% -$5.27M ﹤0.01% 4002
2024
Q3
$8.84M Buy
+662,496
New +$8.81M ﹤0.01% 1899
2024
Q2
Sell
-9,320
Closed -$111K 3871
2024
Q1
$111K Buy
9,320
+7,820
+521% +$66.7K ﹤0.01% 3771
2023
Q4
$6.03K Hold
1,500
﹤0.01% 3885
2023
Q3
$4.11K Hold
1,500
﹤0.01% 3882
2023
Q2
$10K Hold
1,500
﹤0.01% 3893
2023
Q1
$9.57K Hold
1,500
﹤0.01% 3916
2022
Q4
$4K Hold
1,500
﹤0.01% 3946
2022
Q3
$3K Sell
1,500
-300
-17% -$1.03K ﹤0.01% 3945
2022
Q2
$6K Hold
1,800
﹤0.01% 3873
2022
Q1
$7K Hold
1,800
﹤0.01% 3920
2021
Q4
$7K Buy
+1,800
New +$9.6K ﹤0.01% 3949
2021
Q1
Sell
-2,000
Closed -$9K 3841
2020
Q4
$9K Buy
+2,000
New +$8.84K ﹤0.01% 3751

Other funds holding CATX